The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2-Amino-2-iminoethyl)benzyl)-[1,2,4]triazolo[4,3-a]-pyridine-6-carboxamide ID: ALA4875840
PubChem CID: 164627421
Max Phase: Preclinical
Molecular Formula: C16H16N6O
Molecular Weight: 308.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)Cc1ccc(CNC(=O)c2ccc3nncn3c2)cc1
Standard InChI: InChI=1S/C16H16N6O/c17-14(18)7-11-1-3-12(4-2-11)8-19-16(23)13-5-6-15-21-20-10-22(15)9-13/h1-6,9-10H,7-8H2,(H3,17,18)(H,19,23)
Standard InChI Key: UVHMKSXLPYZERP-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
14.0144 -8.7726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0144 -9.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7194 -9.9984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4285 -9.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1376 -9.9984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1376 -10.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4285 -11.2242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7194 -10.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9148 -11.0702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3949 -10.4070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9148 -9.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3053 -9.9984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6004 -9.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8913 -9.9984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8913 -10.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1822 -11.2242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4772 -10.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7681 -11.2242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0590 -10.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3500 -11.2242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0590 -9.9984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4772 -9.9984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1822 -9.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
3 8 1 0
6 9 2 0
9 10 1 0
10 11 2 0
5 11 1 0
2 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
17 22 1 0
22 23 2 0
14 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 308.35Molecular Weight (Monoisotopic): 308.1386AlogP: 1.14#Rotatable Bonds: 5Polar Surface Area: 109.16Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.90CX Basic pKa: 12.27CX LogP: -0.62CX LogD: -2.92Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.48Np Likeness Score: -1.79
References 1. Ma XR, Xu L, Xu S, Klein BJ, Wang H, Das S, Li K, Yang KS, Sohail S, Chapman A, Kutateladze TG, Shi X, Liu WR, Wen H.. (2021) Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain., 64 (15.0): [PMID:34279931 ] [10.1021/acs.jmedchem.1c00367 ]